Windlas Biotech Ltd. (IN:WINDLAS)
:WINDLAS
Want to see IN:WINDLAS full AI Analyst Report?
Total Valuation
Windlas Biotech Ltd. has a market cap or net worth of ₹17.38B. The enterprise value is ₹17.97B.
Market Cap₹17.38B
Enterprise Value₹17.97B
Share Statistics
Windlas Biotech Ltd. has 21,165,873 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,165,873
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Windlas Biotech Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.13%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)9.13%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee7.83M
Profits Per Employee575.88K
Employee Count1,154
Asset Turnover1.00
Inventory Turnover11.97
Valuation Ratios
The current PE Ratio of Windlas Biotech Ltd. is 26.2. Windlas Biotech Ltd.’s PEG ratio is 2.80.
PE Ratio26.2
PS Ratio1.71
PB Ratio2.67
Price to Fair Value2.67
Price to FCF45.88
Price to Operating Cash Flow31.31
PEG Ratio2.80
Income Statement
In the last 12 months, Windlas Biotech Ltd. had revenue of 9.04B and earned 664.56M in profits. Earnings per share was 31.60.
Revenue9.04B
Gross Profit1.64B
Operating Income739.99M
Pretax Income869.77M
Net Income664.56M
EBITDA1.05B
Earnings Per Share (EPS)31.60
Cash Flow
In the last 12 months, operating cash flow was 559.24M and capital expenditures -293.90M, giving a free cash flow of 265.34M billion.
Operating Cash Flow559.24M
Free Cash Flow265.34M
Free Cash Flow per Share12.54
Dividends & Yields
Windlas Biotech Ltd. pays an annual dividend of ₹5.8, resulting in a dividend yield of 0.71%
Dividend Per Share₹5.8
Dividend Yield0.71%
Payout Ratio18.05%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-11.63%
50-Day Moving Average818.51
200-Day Moving Average841.05
Relative Strength Index (RSI)52.74
Average Volume (3m)3.48K
Important Dates
Windlas Biotech Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 21, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Windlas Biotech Ltd. as a current ratio of 1.95, with Debt / Equity ratio of 6.07%
Current Ratio1.95
Quick Ratio1.76
Debt to Market Cap0.02
Net Debt to EBITDA0.32
Interest Coverage Ratio15.33
Taxes
In the past 12 months, Windlas Biotech Ltd. has paid 205.21M in taxes.
Income Tax205.21M
Effective Tax Rate0.24
Enterprise Valuation
Windlas Biotech Ltd. EV to EBITDA ratio is 15.11, with an EV/FCF ratio of 46.87.
EV to Sales1.75
EV to EBITDA15.11
EV to Free Cash Flow46.87
EV to Operating Cash Flow15.60
Balance Sheet
Windlas Biotech Ltd. has ₹2.61B in cash and marketable securities with ₹312.09M in debt, giving a net cash position of ₹2.30B billion.
Cash & Marketable Securities₹2.61B
Total Debt₹312.09M
Net Cash₹2.30B
Net Cash Per Share₹108.70
Tangible Book Value Per Share₹272.91
Margins
Gross margin is 27.40%, with operating margin of 8.18%, and net profit margin of 7.35%.
Gross Margin27.40%
Operating Margin8.18%
Pretax Margin9.62%
Net Profit Margin7.35%
EBITDA Margin11.59%
EBIT Margin8.18%
Analyst Forecast
The average price target for Windlas Biotech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast18.98%
EPS Growth Forecast8.30%